Suvretta Capital Management
Overview
Suvretta Capital Management, LLC was formed in 2011 by Aaron Cowen . Suvretta Capital manages a generalist long/short equity strategy, which began investing on September 1, 2012, and two healthcare-focused long/short equity strategies . The firm employs a global equity strategy, utilizing both long and short positions, that incorporates fundamental analysis, "industry before company" investing, trading, options, risk control management, and an understanding of macro influences on equities . They primarily use equities, futures, ETFs, and equity options to express their investment opinions, preferring to use equity securities and options to hedge risk or enhance their view in a cost-efficient manner .
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Caspian Therapeutics, Inc. | Sep 2026 | Series B | Co-investor |
| Veradermics Inc. | May 2026 | Follow-on Offering | Lead |
| Avalyn Pharma | Jul 2025 | Series D | Lead |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Suvretta Capital Management based?
Suvretta Capital Management is headquartered in New York City, New York, United States.
When was Suvretta Capital Management founded?
Suvretta Capital Management was founded in 2011.
How many portfolio companies does Suvretta Capital Management have?
Suvretta Capital Management has 8 portfolio companies in Caplight's dataset.
What are some companies in Suvretta Capital Management's portfolio?
Recent investments visible on Caplight include Caspian Therapeutics, Inc., Veradermics Inc., Veradermics Inc., Avalyn Pharma, Veradermics Inc..
What was Suvretta Capital Management's most recent investment?
Suvretta Capital Management's most recent investment on Caplight was in Caspian Therapeutics, Inc. in 2026.
What sectors does Suvretta Capital Management focus on?
Suvretta Capital Management focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Energy & Sustainability, Frontier & Industrial Tech, Enterprise Software, AI, Data & Cloud Infrastructure.
What company stages does Suvretta Capital Management focus on?
Suvretta Capital Management typically invests at the MultiStage stage.
What is Suvretta Capital Management's AUM?
Suvretta Capital Management's assets under management are estimated between $1.0B and $10.0B.